| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -55.44M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BCAX returned +101.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +42.0% |
| 1 year | +101.9% |
| All-time high | $29.69 (Jun 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BCAX would be worth today ›No. Bicara Therapeutics Inc. has not paid a dividend in the past 12 months.
Bicara Therapeutics Inc. stock trades on NASDAQ under the ticker symbol BCAX.
Bicara Therapeutics Inc. is part of the Healthcare sector.
Bicara Therapeutics Inc. has a market cap of 1.58B USD, based on the latest quote.
Bicara Therapeutics Inc. is scheduled to report earnings on Nov 10, 2026.
